These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 27784242)

  • 1. Introduction for Design of Nanoparticle Based Drug Delivery Systems.
    Edgar JYC; Wang H
    Curr Pharm Des; 2017; 23(14):2108-2112. PubMed ID: 27784242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
    Ge Z; Liu S
    Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
    Bugno J; Hsu HJ; Hong S
    J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctionality of lipid-core micelles for drug delivery and tumour targeting.
    Sawant RR; Torchilin VP
    Mol Membr Biol; 2010 Oct; 27(7):232-46. PubMed ID: 20929339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in polymeric micelles for drug delivery and tumor targeting.
    Kedar U; Phutane P; Shidhaye S; Kadam V
    Nanomedicine; 2010 Dec; 6(6):714-29. PubMed ID: 20542144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive and active drug targeting: drug delivery to tumors as an example.
    Torchilin VP
    Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.
    Chavanpatil MD; Khdair A; Panyam J
    Pharm Res; 2007 Apr; 24(4):803-10. PubMed ID: 17318416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of nanoparticle shape in cancer drug delivery.
    Truong NP; Whittaker MR; Mak CW; Davis TP
    Expert Opin Drug Deliv; 2015 Jan; 12(1):129-42. PubMed ID: 25138827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micellar nanocarriers: pharmaceutical perspectives.
    Torchilin VP
    Pharm Res; 2007 Jan; 24(1):1-16. PubMed ID: 17109211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer- and liposome-based nanoparticles in targeted drug delivery.
    Venkatraman SS; Ma LL; Natarajan JV; Chattopadhyay S
    Front Biosci (Schol Ed); 2010 Jun; 2(3):801-14. PubMed ID: 20515826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.